thiazolidines has been researched along with Hypertension in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (72.73) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (13.64) | 29.6817 |
| 2010's | 3 (13.64) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aonuma, K; Ishizu, T; Kawakami, Y; Kimura, T; Murakoshi, N; Sai, S; Seo, Y; Suto, Y; Xu, D; Yamamoto, M | 1 |
| Aoyama, M; Bando, YK; Kawase, H; Monji, A; Murohara, T; Nishimura, K | 1 |
| Cui, CF; Gao, N; Gu, J; Li, L; Liu, L; Ouyang, DS; Wang, JJ; Wang, ZS; Wu, WH; Yan, J; Yu, M | 1 |
| Silacci, P | 1 |
| Ikeda, K; Mizutani, K; Tsuda, K; Yamori, Y | 1 |
| Dubinion, JH; Jackson, EK; Mi, Z | 1 |
| Abe, K; Chiba, S; Goto, T; Kasai, Y; Omata, K; Sato, K; Seino, M; Tajima, J; Tanno, M; Yasujima, M | 1 |
| Abe, K; Tajima, J; Tanno, M; Yasujima, M; Yoshinaga, K | 1 |
| Iso, T; Iwao, J; Nakata, K; Nishimura, K; Suda, H; Yamauchi, H | 1 |
| Bönner, G; Ganten, D; Rascher, W; Rockhold, RW; Schaz, K; Schömig, A; Speck, G; Unger, T | 1 |
| Komori, T; Yamamoto, K | 1 |
| DiNicolantonio, R; Doyle, AE; Hutchinson, JS; Mendelsohn, FA | 1 |
| Ganten, D; Lang, RE; Marin-Grez, M; Rascher, W; Unger, T; Yukimura, T | 1 |
| Dinicolantonio, R; Doyle, AE; Hutchinson, JS; Mendelsohn, FA; Takata, Y | 1 |
| Bönner, G; Ganten, D; Rascher, W; Rockhold, RW; Schaz, K; Unger, T; Vescel, P | 1 |
| Ikuse, T; Iso, T; Nakata, K; Nishimura, K; Takada, T; Yamauchi, H | 1 |
| Chiu, S; Johnson, RL; Kwan, CY; Mishra, RK; Naas, F; Rajakumar, G; Singh, AN | 1 |
| Iso, T; Nakata, K; Takada, T; Yamauchi, H | 2 |
| Abe, K; Kohzuki, M; Kudo, K; Omata, K; Onoda, Y; Sasaki, S; Tajima, J; Takeuchi, K; Tanno, M; Tsunoda, K | 1 |
| Iso, T; Nakata, K; Nishimura, K; Takada, T; Yamauchi, H | 1 |
| Dunn, MJ; Ludgin, JR; Ritter, JM; Scharschmidt, LA; Smith, RD | 1 |
1 review(s) available for thiazolidines and Hypertension
| Article | Year |
|---|---|
Advanced glycation end-products as a potential target for treatment of cardiovascular disease.
Topics: Animals; Cardiovascular Diseases; Glycation End Products, Advanced; Humans; Hypertension; Rats; Thiadiazoles; Thiazolidines | 2002 |
1 trial(s) available for thiazolidines and Hypertension
| Article | Year |
|---|---|
Effects of a stable prostaglandin analogue, L-644,122, in healthy and hypertensive men.
Topics: Administration, Oral; Adult; Blood Pressure; Dose-Response Relationship, Drug; Glomerular Filtration Rate; Heart Rate; Hemodynamics; Humans; Hypertension; Infusions, Parenteral; Male; Renal Circulation; Thiazoles; Thiazolidines; Vasodilator Agents | 1985 |
20 other study(ies) available for thiazolidines and Hypertension
| Article | Year |
|---|---|
Teneligliptin Prevents Cardiomyocyte Hypertrophy, Fibrosis, and Development of Hypertensive Heart Failure in Dahl Salt-Sensitive Rats.
Topics: Animals; Blood Pressure; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Fibrosis; Heart Failure; Hypertension; Hypertrophy, Left Ventricular; Male; Myocytes, Cardiac; Pyrazoles; Rats; Rats, Inbred Dahl; Thiazolidines; Treatment Outcome; Ventricular Function, Left | 2018 |
A dipeptidyl peptidase-4 inhibitor ameliorates hypertensive cardiac remodeling via angiotensin-II/sodium-proton pump exchanger-1 axis.
Topics: Angiotensin II; Animals; Blood Pressure; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Echocardiography; Heart Failure; Hypertension; Male; Myocytes, Cardiac; Pyrazoles; Rats; Rats, Inbred SHR; Signal Transduction; Sodium-Hydrogen Exchangers; Thiazolidines; Vasodilation; Ventricular Remodeling | 2016 |
Effects of lignans extracted from Eucommia ulmoides and aldose reductase inhibitor epalrestat on hypertensive vascular remodeling.
Topics: Aldehyde Reductase; Animals; Aorta; Blood Pressure; Captopril; Drugs, Chinese Herbal; Enzyme Inhibitors; Eucommiaceae; Female; Heart Rate; Hypertension; Lignans; Male; Mesenteric Artery, Superior; Plant Bark; Random Allocation; Rats; Rats, Inbred SHR; Rats, Wistar; Rhodanine; Thiazolidines | 2011 |
Inhibitor for advanced glycation end products formation attenuates hypertension and oxidative damage in genetic hypertensive rats.
Topics: Animals; Blood Pressure; Circadian Rhythm; Enzyme Inhibitors; Glycation End Products, Advanced; Hypertension; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Oxidation-Reduction; Rats; Rats, Inbred SHR; RNA, Messenger; Thiadiazoles; Thiazolidines | 2002 |
Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arginine; Blood Pressure; Captopril; Chlorisondamine; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Ganglionic Blockers; Hydralazine; Hypertension; Pentanoic Acids; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Neuropeptide Y; Thiazolidines; Vasodilator Agents | 2008 |
Renal kallikrein-kinin system and the depressor effect of angiotensin converting enzyme inhibitors MK 421, SA 446, and captopril in rats.
Topics: 3-Mercaptopropionic Acid; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Diet, Sodium-Restricted; Dipeptides; Drug Evaluation, Preclinical; Enalapril; Hypertension; Kallikreins; Kinins; Male; Proline; Rats; Rats, Inbred Strains; Sulfhydryl Compounds; Thiazolidines | 1984 |
[Effects of 3 different angiotensin converting enzyme inhibitors, MK 421, SQ 14225 and SA 446 on renal function and blood pressure in patients with essential hypertension].
Topics: 3-Mercaptopropionic Acid; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Dipeptides; Enalapril; Humans; Hypertension; Kidney; Middle Aged; Natriuresis; Potassium; Proline; Renin-Angiotensin System; Sulfhydryl Compounds; Thiazolidines | 1984 |
A new potent inhibitor of converting enzyme: (2R,4R)-2-(2-hydroxyphenyl)-3-(3-mercaptopropionyl)-4-thiazolidinecarboxylic acid(SA446).
Topics: 3-Mercaptopropionic Acid; Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Guinea Pigs; Hypertension; Ileum; In Vitro Techniques; Male; Muscle Contraction; Oligopeptides; Sulfhydryl Compounds; Teprotide; Thiazolidines | 1981 |
Antihypertensive effects of the novel converting-enzyme inhibitor YS 980 in spontaneously hypertensive rats.
Topics: 3-Mercaptopropionic Acid; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Weight; Bradykinin; Catecholamines; Hypertension; Male; Rats; Sulfhydryl Compounds; Thiazoles; Thiazolidines | 1981 |
Effects of YS-980, an orally active converting enzyme inhibitor, on blood pressure in normotensive and hypertensive rats.
Topics: 3-Mercaptopropionic Acid; Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Desoxycorticosterone; Hypertension; Hypertension, Renal; Male; Rats; Rats, Inbred Strains; Sulfhydryl Compounds; Thiazoles; Thiazolidines | 1981 |
In vivo comparison of three orally active inhibitors of angiotensin-converting enzyme.
Topics: 3-Mercaptopropionic Acid; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Dipeptides; Enalapril; Female; Hypertension; Hypertension, Renovascular; Proline; Rats; Rats, Inbred Strains; Sulfhydryl Compounds; Thiazolidines | 1982 |
SA446, a new orally active converting enzyme inhibitor: antihypertensive action and comparison with captopril in stroke-prone spontaneously hypersensitive rats.
Topics: 3-Mercaptopropionic Acid; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Cerebrovascular Disorders; Hypertension; Kallikreins; Male; Natriuresis; Potassium; Proline; Rats; Renin; Sulfhydryl Compounds; Thiazolidines | 1982 |
Mechanisms of converting enzyme inhibition: studies in experimental animals.
Topics: 3-Mercaptopropionic Acid; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Captopril; Dipeptides; Drug Evaluation, Preclinical; Enalapril; Female; Hypertension; Hypertension, Renal; Male; Rats; Rats, Inbred Strains; Thiazolidines | 1984 |
A novel orally active converting-enzyme inhibitor YS 980: effects on blood pressure in spontaneously hypertensive rats.
Topics: 3-Mercaptopropionic Acid; Aldosterone; Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Enkephalin, Leucine; Enkephalins; Hypertension; Kallikreins; Kinins; Male; Rats; Renin; Sulfhydryl Compounds; Thiazoles; Thiazolidines | 1979 |
Effects of an angiotensin-converting enzyme (ACE) inhibitor, SA446, on tissue ACE activity in normotensive, spontaneously hypertensive, and renal hypertensive rats.
Topics: 3-Mercaptopropionic Acid; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Hypertension; Hypertension, Renal; Male; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin; Sodium; Sulfhydryl Compounds; Thiazolidines | 1987 |
L-prolyl-L-leucyl-glycinamide analogues--a new class of peptide antihypertensives.
Topics: Animals; Antihypertensive Agents; Hypertension; Male; MSH Release-Inhibiting Hormone; Rats; Rats, Inbred SHR; Thiazolidines | 1986 |
Effects of sodium loading on antihypertensive responses to an angiotensin-converting enzyme inhibitor in spontaneously hypertensive and renal hypertensive rats.
Topics: 3-Mercaptopropionic Acid; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Hypertension; Hypertension, Renal; Rats; Rats, Inbred SHR; Renin; Sodium; Sulfhydryl Compounds; Thiazolidines | 1986 |
Effects of three different kininase II inhibitors on blood pressure and renal vasoactive substances in essential hypertensives.
Topics: 3-Mercaptopropionic Acid; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Captopril; Enalapril; Female; Humans; Hypertension; Kallikreins; Kidney; Kinins; Male; Middle Aged; Pulse; Renin; Sulfhydryl Compounds; Thiazolidines | 1986 |
[Antihypertensive effects of SA446, hydralazine and the combination on renal hypertensive rats and spontaneously hypertensive rats by long-term treatment].
Topics: 3-Mercaptopropionic Acid; Animals; Antihypertensive Agents; Body Weight; Diuresis; Drinking; Drug Therapy, Combination; Hydralazine; Hypertension; Hypertension, Renal; Male; Rats; Rats, Inbred SHR; Sulfhydryl Compounds; Thiazolidines | 1986 |
[Combined effect of (2R, 4R)-2-(o-hydroxyphenyl)-3-(3-mercaptopropionyl)-4-thiazolidinecarbo xyl ic acid (SA446) with hydrochlorothiazide or propranolol on development of hypertension in spontaneously hypertensive rats (SHR) by long-term administration].
Topics: 3-Mercaptopropionic Acid; Animals; Antihypertensive Agents; Diuresis; Hydrochlorothiazide; Hypertension; Natriuresis; Propranolol; Rats; Rats, Inbred SHR; Renin-Angiotensin System; Sulfhydryl Compounds; Thiazolidines | 1986 |